- Corporate Officers - N
- Nea 16 Gp, Llc
Insider Trading History of Nea 16 Gp, Llc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Nea 16 Gp, Llc since 2019.
This trader's CIK number is 1712882.
At the time of last reporting, Nea 16 Gp, Llc was the 10% Owner of Genocea Biosciences, Inc.. (stock ticker symbol GNCA).
Also see all insider trading activities at Genocea Biosciences, Inc..
Note that in the past
NEA 16 GP, LLC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Akouos, Inc. (AKUS) by Nea 16 Gp, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | AKUS | 588,235 | $9,999,995 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Genocea Biosciences, Inc. (GNCA) by Nea 16 Gp, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | GNCA | 0 | $0 | 10,376,936 | $750,066 | 0 | $0 |
| 2020 | GNCA | 3,151,260 | $7,090,335 | 0 | $0 | 0 | $0 |
| 2019 | GNCA | 12,805,411 | $14,685,631 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Trevi Therapeutics, Inc. (TRVI) by Nea 16 Gp, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | TRVI | 2,631,578 | $4,999,998 | 0 | $0 | 0 | $0 |
| 2021 | TRVI | 1,851,852 | $0 | 0 | $0 | 0 | $0 |
| 2020 | TRVI | 0 | $0 | 564 | $1,500 | 0 | $0 |
| 2019 | TRVI | 2,500,000 | $25,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Regulus Therapeutics Inc. (RGLS) by Nea 16 Gp, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | RGLS | 4,398,602 | $2,735,930 | 0 | $0 | 0 | $0 |
| 2019 | RGLS | 1,136,704 | $1,227,640 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Marker Therapeutics, Inc. (MRKR) by Nea 16 Gp, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | MRKR | 5,714,285 | $9,999,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Mirum Pharmaceuticals, Inc. (MIRM) by Nea 16 Gp, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | MIRM | 450,000 | $6,750,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Metacrine, Inc. (MTCR) by Nea 16 Gp, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | MTCR | 0 | $0 | 497,270 | $489,102 | 0 | $0 |
| 2020 | MTCR | 769,230 | $9,999,990 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Nea 16 Gp, Llc:
1. Akouos, Inc. (AKUS)
2. Genocea Biosciences, Inc. (GNCA)
3. Trevi Therapeutics, Inc. (TRVI)
4. Regulus Therapeutics Inc. (RGLS)
5. Marker Therapeutics, Inc. (MRKR)
6. Mirum Pharmaceuticals, Inc. (MIRM)
7. Metacrine, Inc. (MTCR)
Table 1. Insider trading of Akouos, Inc. (AKUS) by Nea 16 Gp, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-30 | AKUS | Buy | 588,235 | 17.00 | 9,999,995 |
Table 2. Insider trading of Genocea Biosciences, Inc. (GNCA) by Nea 16 Gp, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-05-24 | GNCA | Sale | 5,931,843 | .07 | 385,569 |
| 2022-05-25 | GNCA | Sale | 4,445,093 | .08 | 364,497 |
| 2020-07-24 | GNCA | Buy | 3,151,260 | 2.25 | 7,090,335 |
| 2019-06-24 | GNCA | Buy | 2,857,142 | 3.50 | 9,999,997 |
| 2019-02-14 | GNCA | Buy | 9,948,269 | .47 | 4,685,634 |
Table 3. Insider trading of Trevi Therapeutics, Inc. (TRVI) by Nea 16 Gp, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-04-11 | TRVI | Buy | 2,631,578 | 1.90 | 4,999,998 |
| 2021-10-18 | TRVI | Buy | 1,851,852 | .00 | 0 |
| 2020-04-03 | TRVI | Sale | 564 | 2.66 | 1,500 |
| 2019-05-09 | TRVI | Buy | 2,500,000 | 10.00 | 25,000,000 |
Table 4. Insider trading of Regulus Therapeutics Inc. (RGLS) by Nea 16 Gp, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-12-04 | RGLS | Buy | 4,398,602 | .62 | 2,735,930 |
| 2019-05-07 | RGLS | Buy | 1,136,704 | 1.08 | 1,227,640 |
Table 5. Insider trading of Marker Therapeutics, Inc. (MRKR) by Nea 16 Gp, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-03-16 | MRKR | Buy | 5,714,285 | 1.75 | 9,999,998 |
Table 6. Insider trading of Mirum Pharmaceuticals, Inc. (MIRM) by Nea 16 Gp, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-07-22 | MIRM | Buy | 450,000 | 15.00 | 6,750,000 |
Table 7. Insider trading of Metacrine, Inc. (MTCR) by Nea 16 Gp, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-12-10 | MTCR | Sale | 37,570 | 1.32 | 49,629 |
| 2021-12-22 | MTCR | Sale | 459,700 | .96 | 439,473 |
| 2020-09-18 | MTCR | Buy | 769,230 | 13.00 | 9,999,990 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Nea 16 Gp, Llc
(10% Owner of Genocea Biosciences, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.